Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1982-01-06
1984-09-18
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
206569, 422 61, 424 9, A61K 4300, A61K 4900, B65D 7100
Patent
active
044723717
ABSTRACT:
Antibodies to human carcinoembryonic antigen (CEA), human alphafetoprotein (AFP) and/or to other anti-human tumor associated antigens (TAA) labeled with technetium-99m (Tc-99m) are administered to a human after the human has been administered anti-CEA, anti-AFP and/or other anti-TAAs, such as human melanoma-associated antigen, human neuroblastoma-associated antigen, human breast cancer-associated antigen, human ovary-associated antigen, human sarcoma-associated antigen, etc. The biodistribution of the labeled product composition accumulates at cancer sites, e.g., tumors that produce or express TAA, due to the affinity that the antibody has for the given tumor antigen. The accumulation at the tumor site(s) of a suitable amount of Tc-99m associated with the antibody allows detection via external scintigraphy and other means. Detection of the Tc-99m antibody composition by external scintigraphy permits localization and detection of tumors in vivo via a semi-noninvasive technique.
REFERENCES:
patent: 4116776 (1978-09-01), Dalbow et al.
patent: 4311688 (1982-01-01), Burchiel et al.
patent: 4323546 (1982-04-01), Crockford
patent: 4361544 (1982-11-01), Goldenberg
Burchiel Scott W.
Crockford David R.
Rhodes Buck A.
Cook Paul J.
Nucker Christine M.
Summa Medical Corporation
University Patents Inc.
LandOfFree
Radiolabeled antibody to anti-tumor associated antigen and proce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled antibody to anti-tumor associated antigen and proce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled antibody to anti-tumor associated antigen and proce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793494